What is peritoneal adenocarcinoma?
Peritoneal adenocarcinoma is a type of abdominal cancer that begins in the lining of peritoneum - a membrane covering the inner wall of the abdominal cavity - and then spreads to other abdominal and pelvic organs. This cancer comes from epithelial tissue - or tissue membranes and lining in the body - and is characterized as an epithelial or cancer cancer. However, it is an extremely rare form of epithelial cancer, although these cancers make up about 85% of all cancer malignancies. These links generally identify peritoneal adenocarcinoma, which occurs mainly in women, especially women of past age who have been removed by the ovaries. Cancer has been found to have clinical traits similar to pelvic reproductive cancer such as ovarian cancer, despite the absence of ovaries. Moreover, it has generally concluded that cancer is based on a pelvis or abdomen lining instead of ovaries.
peritoneal adenocarcinoma is called primary peritoneal carcinoma or PPCA and is also known as extraovArian primary peritoneal carcinoma or EOPPC, as well as primary peritoneal papillary papillary adenocarcinoma. It has also been felt that it resembles peritoneal mesothelioma, but the peritoneal mesothelioma has become more identified with the deadly type of cancer associated with asbestos and the EOPPC was not associated with the asbestos exposure.
The causes of peritoneal adenocarcinoma remain unclear. It is a recently recognized form of cancer, with unknown risk factors and still defined doctors, some of whom believe that this may have previously been incorrectly diagnosed as ovarian cancer. Others believe it can grow. Cancer Centerstato Statistics and Prevalence of Cancer in the population currently estimate that EOPPC appears in a ratio of about 1:10 cases of ovarian cancer, and about 500 reports are in a set that identifies peritoneal adenocarcinoma as a type of cancer.
Symptoms of PERitoneal adenocarcinoma may include those similar to many other abdominal disorders such as pain or abdominal discomfort, nausea or fullness. It was also found that about 85% of patients diagnosed with peritoneal adenocarcinoma had Ascity or unusual amounts of fluid in the abdominal region. In laboratory tests, many patients had a high level of tumor indicator called the CA-125.
Peritoneal adenocarcinoma can quickly develop into carcinomatosis. This means that it can metastasize or spread throughout the body into areas such as liver and brain. Carcinomatosis is treated with an surgery called peritonectomy that removes partiperitoneum or stomach lining. It has been found to be useful with regard to tailor -made survival from this type of cancer.